Matrix Metalloprotease Inhibitors
| Cat. No. | Product Name / Activity |
|---|---|
| 2621 | ARP 100 |
| Selective inhibitor of MMP-2 | |
| 2622 | ARP 101 |
| Inhibitor of MMP-2 | |
| 2961 | Batimastat |
| Potent, broad spectrum MMP inhibitor | |
| 2632 | CL 82198 hydrochloride |
| Selective inhibitor of MMP-13 | |
| 4090 | Doxycycline hyclate |
| Broad-spectrum MMP inhibitor; tetracycline derivative | |
| 2983 | GM 6001 |
| Broad spectrum MMP inhibitor | |
| 7030 | GW 280264X |
| Potent ADAM10 and ADAM17 endopeptidase nhibitor | |
| 6439 | JNJ 0966 |
| Pro-MMP9 activation inhibitor | |
| 2631 | Marimastat |
| Broad spectrum MMP inhibitor | |
| 3268 | Minocycline hydrochloride |
| Inhibitor of MMP activity | |
| 4902 | NSC 405020 |
| Inhibitor of MT1-MMP; antitumor | |
| 2520 | PD 166793 |
| Broad spectrum MMP inhibitor | |
| 6088 | SB 3CT |
| High affinity and selective MMP2 inhibitor | |
| 4775 | SD 2590 hydrochloride |
| Potent MMP inhibitor | |
| 6134 | T 26c disodium salt |
| Highly potent and selective MMP13 inhibitor | |
| 5523 | TAPI 0 |
| ADAM-17 (TACE) and MMP inhibitor | |
| 6162 | TAPI 1 |
| ADAM-17 (TACE) and MMP inhibitor | |
| 6013 | TAPI 2 |
| ADAM-17 (TACE) and MMP inhibitor | |
| 2900 | UK 370106 |
| Highly selective MMP-3 and MMP-12 inhibitor | |
| 4188 | UK 383367 |
| Potent and selective BMP-1 (PCP) inhibitor | |
| 2633 | WAY 170523 |
| Potent and selective inhibitor of MMP-13 |
Cancer Research Product Guide
Our Cancer Research Guide highlights over 750 products for cancer research.
Request copyRequest PDFAngiogenesis in Cancer Life Science Poster
Taken from the Cancer Product Guide Edition 3
Our Angiogenesis in Cancer poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets.
Request copyDownload PDFCardiovascular Life Science Poster
Written by J.J. Maguire and A.P. Davenport
Our Cardiovascular poster highlights the key G protein-coupled receptors involved in the regulation of vascular reactivity.
Request copyDownload PDF